HEADER TRANSFERASE 12-FEB-09 3G8E
TITLE CRYSTAL STRUCTURE OF RATTUS NORVEGICUS VISFATIN/PBEF/NAMPT IN COMPLEX
TITLE 2 WITH AN FK866-BASED INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: NAMPRTASE, NAMPT, PRE-B-CELL COLONY-ENHANCING FACTOR 1
COMPND 5 HOMOLOG, PBEF, VISFATIN;
COMPND 6 EC: 2.4.2.12;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS;
SOURCE 3 ORGANISM_COMMON: RAT;
SOURCE 4 ORGANISM_TAXID: 10116;
SOURCE 5 GENE: VISFATIN;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS PROTEIN-LIGAND COMPLEX, IS001, CYTOPLASM, GLYCOSYLTRANSFERASE,
KEYWDS 2 NUCLEUS, PHOSPHOPROTEIN, PYRIDINE NUCLEOTIDE BIOSYNTHESIS,
KEYWDS 3 TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR G.B.KANG,M.H.BAE,M.K.KIM,I.IM,Y.C.KIM,S.H.EOM
REVDAT 2 01-NOV-23 3G8E 1 REMARK
REVDAT 1 18-AUG-09 3G8E 0
JRNL AUTH G.B.KANG,M.H.BAE,M.K.KIM,I.IM,Y.C.KIM,S.H.EOM
JRNL TITL CRYSTAL STRUCTURE OF RATTUS NORVEGICUS VISFATIN/PBEF/NAMPT
JRNL TITL 2 IN COMPLEX WITH AN FK866-BASED INHIBITOR
JRNL REF MOL.CELLS V. 27 667 2009
JRNL REFN ISSN 1016-8478
JRNL PMID 19533035
JRNL DOI 10.1007/S10059-009-0088-X
REMARK 2
REMARK 2 RESOLUTION. 3.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS 1.1
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : 19768
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.253
REMARK 3 FREE R VALUE : 0.299
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 1941
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.3270
REMARK 3 BIN FREE R VALUE : 0.3920
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 278
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 7400
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 76
REMARK 3 SOLVENT ATOMS : 0
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.800
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 3G8E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-FEB-09.
REMARK 100 THE DEPOSITION ID IS D_1000051552.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 17-FEB-06
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : PAL/PLS
REMARK 200 BEAMLINE : 4A
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22256
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7
REMARK 200 DATA REDUNDANCY : 7.400
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.14000
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.4000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.05
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 7.50
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.33400
REMARK 200 <I/SIGMA(I)> FOR SHELL : 8.250
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: PDB ENTRY 2G95
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 49.21
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES-NAOH, 16% PEG 3350, 0.2M
REMARK 280 MAGNESIUM CHLORIDE, PH 7.5, VAPOR DIFFUSION, TEMPERATURE 294K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.65800
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.09750
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.70300
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.09750
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.65800
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.70300
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 8210 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 31750 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 1
REMARK 465 ASN A 2
REMARK 465 ALA A 3
REMARK 465 ALA A 4
REMARK 465 ALA A 5
REMARK 465 GLU A 6
REMARK 465 ALA A 7
REMARK 465 GLU A 8
REMARK 465 LYS A 42
REMARK 465 LYS A 43
REMARK 465 THR A 44
REMARK 465 GLU A 45
REMARK 465 ASN A 46
REMARK 465 SER A 47
REMARK 465 LYS A 48
REMARK 465 VAL A 49
REMARK 465 ARG A 50
REMARK 465 LYS A 51
REMARK 465 VAL A 52
REMARK 465 LYS A 53
REMARK 465 MET A 484
REMARK 465 GLU A 485
REMARK 465 GLN A 486
REMARK 465 ASP A 487
REMARK 465 VAL A 488
REMARK 465 ALA A 489
REMARK 465 PRO A 490
REMARK 465 HIS A 491
REMARK 465 MET B 1
REMARK 465 ASN B 2
REMARK 465 ALA B 3
REMARK 465 ALA B 4
REMARK 465 ALA B 5
REMARK 465 GLU B 6
REMARK 465 ALA B 7
REMARK 465 GLU B 8
REMARK 465 LYS B 42
REMARK 465 LYS B 43
REMARK 465 THR B 44
REMARK 465 GLU B 45
REMARK 465 ASN B 46
REMARK 465 SER B 47
REMARK 465 LYS B 48
REMARK 465 VAL B 49
REMARK 465 ARG B 50
REMARK 465 LYS B 51
REMARK 465 VAL B 52
REMARK 465 LYS B 53
REMARK 465 MET B 484
REMARK 465 GLU B 485
REMARK 465 GLN B 486
REMARK 465 ASP B 487
REMARK 465 VAL B 488
REMARK 465 ALA B 489
REMARK 465 PRO B 490
REMARK 465 HIS B 491
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O LEU A 432 CD1 LEU A 457 1.90
REMARK 500 O PRO B 113 OG1 THR B 137 2.07
REMARK 500 NZ LYS A 32 OE1 GLU A 135 2.08
REMARK 500 O GLU A 98 ND2 ASN A 102 2.13
REMARK 500 OH TYR B 54 ND2 ASN B 164 2.16
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION
REMARK 500 LEU A 432 C LEU A 432 O -0.121
REMARK 500 LEU A 457 CG LEU A 457 CD1 -0.280
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG B 196 NE - CZ - NH1 ANGL. DEV. = -3.3 DEGREES
REMARK 500 PRO B 346 C - N - CA ANGL. DEV. = 9.8 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN A 10 90.22 161.90
REMARK 500 SER A 17 -52.73 -21.57
REMARK 500 TYR A 18 8.90 -62.91
REMARK 500 TYR A 64 -70.32 -76.63
REMARK 500 TYR A 69 -35.16 -140.31
REMARK 500 LYS A 71 163.71 -46.99
REMARK 500 GLU A 85 -27.51 78.24
REMARK 500 VAL A 86 -60.02 -108.13
REMARK 500 TYR A 87 46.63 -73.11
REMARK 500 ARG A 88 -42.97 -146.27
REMARK 500 ASP A 93 150.16 170.70
REMARK 500 PRO A 126 -175.32 -52.41
REMARK 500 THR A 145 -75.80 -29.00
REMARK 500 THR A 150 -77.33 -40.89
REMARK 500 GLN A 154 25.56 -63.89
REMARK 500 TYR A 157 -73.82 -80.04
REMARK 500 GLU A 187 1.12 -52.30
REMARK 500 TYR A 195 -53.54 -29.40
REMARK 500 TYR A 231 -32.33 -134.75
REMARK 500 PRO A 236 -33.08 -37.62
REMARK 500 VAL A 237 138.68 160.85
REMARK 500 ILE A 250 -50.39 -130.39
REMARK 500 PHE A 269 33.11 -95.94
REMARK 500 SER A 271 -87.39 -31.95
REMARK 500 VAL A 272 -168.82 -105.38
REMARK 500 ASP A 282 108.81 8.34
REMARK 500 ILE A 283 31.57 -85.37
REMARK 500 GLU A 288 -78.05 -67.69
REMARK 500 GLU A 293 -82.90 -142.26
REMARK 500 ARG A 296 -13.08 -48.81
REMARK 500 ILE A 299 -62.71 -120.82
REMARK 500 SER A 301 33.88 -93.04
REMARK 500 ASP A 313 46.49 -151.68
REMARK 500 SER A 314 -119.00 -93.67
REMARK 500 ASN A 316 98.53 83.65
REMARK 500 SER A 338 -0.24 -51.04
REMARK 500 PRO A 346 -17.09 -32.66
REMARK 500 LYS A 372 37.94 87.32
REMARK 500 SER A 374 129.84 -34.59
REMARK 500 PHE A 414 173.76 173.47
REMARK 500 ALA A 419 5.73 -64.58
REMARK 500 ASP A 420 118.95 179.53
REMARK 500 PRO A 421 -150.22 -88.52
REMARK 500 ASN A 422 -20.68 59.01
REMARK 500 PRO A 436 1.00 -56.67
REMARK 500 THR A 439 -147.71 -70.27
REMARK 500 VAL A 441 135.49 -171.81
REMARK 500 LYS A 447 -6.32 -56.26
REMARK 500 GLU A 451 80.25 -61.57
REMARK 500 HIS A 455 91.47 72.25
REMARK 500
REMARK 500 THIS ENTRY HAS 112 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IS1 A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IS1 B 502
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 2G97 RELATED DB: PDB
REMARK 900 THE SAME PROTEIN COMPLEXED WITH FK-866
REMARK 900 RELATED ID: 2G96 RELATED DB: PDB
REMARK 900 THE SAME PROTEIN COMPLEXED WITH NMN
DBREF 3G8E A 1 491 UNP Q80Z29 NAMPT_RAT 1 491
DBREF 3G8E B 1 491 UNP Q80Z29 NAMPT_RAT 1 491
SEQRES 1 A 491 MET ASN ALA ALA ALA GLU ALA GLU PHE ASN ILE LEU LEU
SEQRES 2 A 491 ALA THR ASP SER TYR LYS VAL THR HIS TYR LYS GLN TYR
SEQRES 3 A 491 PRO PRO ASN THR SER LYS VAL TYR SER TYR PHE GLU CYS
SEQRES 4 A 491 ARG GLU LYS LYS THR GLU ASN SER LYS VAL ARG LYS VAL
SEQRES 5 A 491 LYS TYR GLU GLU THR VAL PHE TYR GLY LEU GLN TYR ILE
SEQRES 6 A 491 LEU ASN LYS TYR LEU LYS GLY LYS VAL VAL THR LYS GLU
SEQRES 7 A 491 LYS ILE GLN GLU ALA LYS GLU VAL TYR ARG GLU HIS PHE
SEQRES 8 A 491 GLN ASP ASP VAL PHE ASN GLU ARG GLY TRP ASN TYR ILE
SEQRES 9 A 491 LEU GLU LYS TYR ASP GLY HIS LEU PRO ILE GLU VAL LYS
SEQRES 10 A 491 ALA VAL PRO GLU GLY SER VAL ILE PRO ARG GLY ASN VAL
SEQRES 11 A 491 LEU PHE THR VAL GLU ASN THR ASP PRO GLU CYS TYR TRP
SEQRES 12 A 491 LEU THR ASN TRP ILE GLU THR ILE LEU VAL GLN SER TRP
SEQRES 13 A 491 TYR PRO ILE THR VAL ALA THR ASN SER ARG GLU GLN LYS
SEQRES 14 A 491 LYS ILE LEU ALA LYS TYR LEU LEU GLU THR SER GLY ASN
SEQRES 15 A 491 LEU ASP GLY LEU GLU TYR LYS LEU HIS ASP PHE GLY TYR
SEQRES 16 A 491 ARG GLY VAL SER SER GLN GLU THR ALA GLY ILE GLY ALA
SEQRES 17 A 491 SER ALA HIS LEU VAL ASN PHE LYS GLY THR ASP THR VAL
SEQRES 18 A 491 ALA GLY ILE ALA LEU ILE LYS LYS TYR TYR GLY THR LYS
SEQRES 19 A 491 ASP PRO VAL PRO GLY TYR SER VAL PRO ALA ALA GLU HIS
SEQRES 20 A 491 SER THR ILE THR ALA TRP GLY LYS ASP HIS GLU LYS ASP
SEQRES 21 A 491 ALA PHE GLU HIS ILE VAL THR GLN PHE SER SER VAL PRO
SEQRES 22 A 491 VAL SER VAL VAL SER ASP SER TYR ASP ILE TYR ASN ALA
SEQRES 23 A 491 CYS GLU LYS ILE TRP GLY GLU ASP LEU ARG HIS LEU ILE
SEQRES 24 A 491 VAL SER ARG SER THR GLU ALA PRO LEU ILE ILE ARG PRO
SEQRES 25 A 491 ASP SER GLY ASN PRO LEU ASP THR VAL LEU LYS VAL LEU
SEQRES 26 A 491 ASP ILE LEU GLY LYS LYS PHE PRO VAL SER GLU ASN SER
SEQRES 27 A 491 LYS GLY TYR LYS LEU LEU PRO PRO TYR LEU ARG VAL ILE
SEQRES 28 A 491 GLN GLY ASP GLY VAL ASP ILE ASN THR LEU GLN GLU ILE
SEQRES 29 A 491 VAL GLU GLY MET LYS GLN LYS LYS TRP SER ILE GLU ASN
SEQRES 30 A 491 VAL SER PHE GLY SER GLY GLY ALA LEU LEU GLN LYS LEU
SEQRES 31 A 491 THR ARG ASP LEU LEU ASN CYS SER PHE LYS CYS SER TYR
SEQRES 32 A 491 VAL VAL THR ASN GLY LEU GLY VAL ASN VAL PHE LYS ASP
SEQRES 33 A 491 PRO VAL ALA ASP PRO ASN LYS ARG SER LYS LYS GLY ARG
SEQRES 34 A 491 LEU SER LEU HIS ARG THR PRO ALA GLY THR PHE VAL THR
SEQRES 35 A 491 LEU GLU GLU GLY LYS GLY ASP LEU GLU GLU TYR GLY HIS
SEQRES 36 A 491 ASP LEU LEU HIS THR VAL PHE LYS ASN GLY LYS VAL THR
SEQRES 37 A 491 LYS SER TYR SER PHE ASP GLU VAL ARG LYS ASN ALA GLN
SEQRES 38 A 491 LEU ASN MET GLU GLN ASP VAL ALA PRO HIS
SEQRES 1 B 491 MET ASN ALA ALA ALA GLU ALA GLU PHE ASN ILE LEU LEU
SEQRES 2 B 491 ALA THR ASP SER TYR LYS VAL THR HIS TYR LYS GLN TYR
SEQRES 3 B 491 PRO PRO ASN THR SER LYS VAL TYR SER TYR PHE GLU CYS
SEQRES 4 B 491 ARG GLU LYS LYS THR GLU ASN SER LYS VAL ARG LYS VAL
SEQRES 5 B 491 LYS TYR GLU GLU THR VAL PHE TYR GLY LEU GLN TYR ILE
SEQRES 6 B 491 LEU ASN LYS TYR LEU LYS GLY LYS VAL VAL THR LYS GLU
SEQRES 7 B 491 LYS ILE GLN GLU ALA LYS GLU VAL TYR ARG GLU HIS PHE
SEQRES 8 B 491 GLN ASP ASP VAL PHE ASN GLU ARG GLY TRP ASN TYR ILE
SEQRES 9 B 491 LEU GLU LYS TYR ASP GLY HIS LEU PRO ILE GLU VAL LYS
SEQRES 10 B 491 ALA VAL PRO GLU GLY SER VAL ILE PRO ARG GLY ASN VAL
SEQRES 11 B 491 LEU PHE THR VAL GLU ASN THR ASP PRO GLU CYS TYR TRP
SEQRES 12 B 491 LEU THR ASN TRP ILE GLU THR ILE LEU VAL GLN SER TRP
SEQRES 13 B 491 TYR PRO ILE THR VAL ALA THR ASN SER ARG GLU GLN LYS
SEQRES 14 B 491 LYS ILE LEU ALA LYS TYR LEU LEU GLU THR SER GLY ASN
SEQRES 15 B 491 LEU ASP GLY LEU GLU TYR LYS LEU HIS ASP PHE GLY TYR
SEQRES 16 B 491 ARG GLY VAL SER SER GLN GLU THR ALA GLY ILE GLY ALA
SEQRES 17 B 491 SER ALA HIS LEU VAL ASN PHE LYS GLY THR ASP THR VAL
SEQRES 18 B 491 ALA GLY ILE ALA LEU ILE LYS LYS TYR TYR GLY THR LYS
SEQRES 19 B 491 ASP PRO VAL PRO GLY TYR SER VAL PRO ALA ALA GLU HIS
SEQRES 20 B 491 SER THR ILE THR ALA TRP GLY LYS ASP HIS GLU LYS ASP
SEQRES 21 B 491 ALA PHE GLU HIS ILE VAL THR GLN PHE SER SER VAL PRO
SEQRES 22 B 491 VAL SER VAL VAL SER ASP SER TYR ASP ILE TYR ASN ALA
SEQRES 23 B 491 CYS GLU LYS ILE TRP GLY GLU ASP LEU ARG HIS LEU ILE
SEQRES 24 B 491 VAL SER ARG SER THR GLU ALA PRO LEU ILE ILE ARG PRO
SEQRES 25 B 491 ASP SER GLY ASN PRO LEU ASP THR VAL LEU LYS VAL LEU
SEQRES 26 B 491 ASP ILE LEU GLY LYS LYS PHE PRO VAL SER GLU ASN SER
SEQRES 27 B 491 LYS GLY TYR LYS LEU LEU PRO PRO TYR LEU ARG VAL ILE
SEQRES 28 B 491 GLN GLY ASP GLY VAL ASP ILE ASN THR LEU GLN GLU ILE
SEQRES 29 B 491 VAL GLU GLY MET LYS GLN LYS LYS TRP SER ILE GLU ASN
SEQRES 30 B 491 VAL SER PHE GLY SER GLY GLY ALA LEU LEU GLN LYS LEU
SEQRES 31 B 491 THR ARG ASP LEU LEU ASN CYS SER PHE LYS CYS SER TYR
SEQRES 32 B 491 VAL VAL THR ASN GLY LEU GLY VAL ASN VAL PHE LYS ASP
SEQRES 33 B 491 PRO VAL ALA ASP PRO ASN LYS ARG SER LYS LYS GLY ARG
SEQRES 34 B 491 LEU SER LEU HIS ARG THR PRO ALA GLY THR PHE VAL THR
SEQRES 35 B 491 LEU GLU GLU GLY LYS GLY ASP LEU GLU GLU TYR GLY HIS
SEQRES 36 B 491 ASP LEU LEU HIS THR VAL PHE LYS ASN GLY LYS VAL THR
SEQRES 37 B 491 LYS SER TYR SER PHE ASP GLU VAL ARG LYS ASN ALA GLN
SEQRES 38 B 491 LEU ASN MET GLU GLN ASP VAL ALA PRO HIS
HET IS1 A 501 38
HET IS1 B 502 38
HETNAM IS1 3-[(1E)-3-OXO-3-({4-[1-(PHENYLCARBONYL)PIPERIDIN-4-
HETNAM 2 IS1 YL]BUTYL}AMINO)PROP-1-EN-1-YL]-1-BETA-D-
HETNAM 3 IS1 RIBOFURANOSYLPYRIDINIUM
HETSYN IS1 3-((E)-3-(4-(1-BENZOYLPIPERIDIN-4-YL)BUTYLAMINO)-3-
HETSYN 2 IS1 OXOPROP-1-ENYL)-1-((2R,3R,4S,5R)-3,4-DIHYDROXY-5-
HETSYN 3 IS1 (HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)PYRIDINIUM
FORMUL 3 IS1 2(C29 H38 N3 O6 1+)
HELIX 1 1 ASN A 10 ALA A 14 5 5
HELIX 2 2 ASP A 16 VAL A 20 5 5
HELIX 3 3 THR A 21 GLN A 25 5 5
HELIX 4 4 GLY A 61 LEU A 70 1 10
HELIX 5 5 THR A 76 LYS A 84 1 9
HELIX 6 6 ASN A 97 TYR A 108 1 12
HELIX 7 7 TRP A 143 ILE A 148 1 6
HELIX 8 8 ILE A 148 GLN A 154 1 7
HELIX 9 9 SER A 155 GLY A 181 1 27
HELIX 10 10 GLY A 185 TYR A 188 5 4
HELIX 11 11 GLY A 194 VAL A 198 5 5
HELIX 12 12 SER A 200 SER A 209 1 10
HELIX 13 13 VAL A 221 TYR A 231 1 11
HELIX 14 14 HIS A 247 ALA A 252 1 6
HELIX 15 15 TRP A 253 ASP A 256 5 4
HELIX 16 16 HIS A 257 VAL A 266 1 10
HELIX 17 17 GLU A 288 GLU A 293 1 6
HELIX 18 18 ARG A 296 SER A 301 1 6
HELIX 19 19 ASN A 316 PHE A 332 1 17
HELIX 20 20 ASP A 357 LYS A 371 1 15
HELIX 21 21 GLY A 383 GLN A 388 1 6
HELIX 22 22 THR A 391 LEU A 395 5 5
HELIX 23 23 GLY A 446 LEU A 450 5 5
HELIX 24 24 SER A 472 ALA A 480 1 9
HELIX 25 25 ASN B 10 ALA B 14 5 5
HELIX 26 26 ASP B 16 GLN B 25 5 10
HELIX 27 27 GLY B 61 TYR B 69 1 9
HELIX 28 28 THR B 76 HIS B 90 1 15
HELIX 29 29 ASN B 97 ASP B 109 1 13
HELIX 30 30 GLU B 140 TYR B 142 5 3
HELIX 31 31 TRP B 143 ILE B 148 1 6
HELIX 32 32 GLU B 149 GLN B 154 5 6
HELIX 33 33 SER B 155 GLY B 181 1 27
HELIX 34 34 GLY B 185 TYR B 188 5 4
HELIX 35 35 GLY B 194 GLY B 197 5 4
HELIX 36 36 SER B 200 VAL B 213 1 14
HELIX 37 37 THR B 220 TYR B 231 1 12
HELIX 38 38 HIS B 247 ALA B 252 1 6
HELIX 39 39 HIS B 257 PHE B 269 1 13
HELIX 40 40 GLU B 288 GLU B 293 1 6
HELIX 41 41 LEU B 295 ILE B 299 5 5
HELIX 42 42 ASN B 316 PHE B 332 1 17
HELIX 43 43 ASP B 357 LYS B 371 1 15
HELIX 44 44 GLY B 383 GLN B 388 1 6
HELIX 45 45 ASP B 393 LEU B 395 5 3
HELIX 46 46 GLY B 446 LEU B 450 5 5
HELIX 47 47 SER B 472 ALA B 480 1 9
SHEET 1 A 6 LEU A 409 ASN A 412 0
SHEET 2 A 6 CYS A 397 THR A 406 -1 N VAL A 404 O VAL A 411
SHEET 3 A 6 THR A 30 CYS A 39 -1 N TYR A 36 O LYS A 400
SHEET 4 A 6 VAL A 130 ASN A 136 -1 O VAL A 134 N SER A 35
SHEET 5 A 6 ILE A 114 ALA A 118 -1 N GLU A 115 O GLU A 135
SHEET 6 A 6 HIS A 459 LYS A 463 -1 O PHE A 462 N VAL A 116
SHEET 1 B 2 GLU A 56 VAL A 58 0
SHEET 2 B 2 VAL A 124 PRO A 126 -1 O ILE A 125 N THR A 57
SHEET 1 C 5 LEU A 190 ASP A 192 0
SHEET 2 C 5 VAL A 378 SER A 382 1 O PHE A 380 N HIS A 191
SHEET 3 C 5 LEU A 348 GLN A 352 1 N GLN A 352 O GLY A 381
SHEET 4 C 5 LEU A 308 ARG A 311 1 N ILE A 310 O ARG A 349
SHEET 5 C 5 VAL A 274 VAL A 277 1 N VAL A 274 O ILE A 309
SHEET 1 D 2 SER A 335 GLU A 336 0
SHEET 2 D 2 LYS A 342 LEU A 343 -1 O LEU A 343 N SER A 335
SHEET 1 E 2 SER A 431 ARG A 434 0
SHEET 2 E 2 PHE A 440 LEU A 443 -1 O VAL A 441 N HIS A 433
SHEET 1 F 6 VAL B 411 ASN B 412 0
SHEET 2 F 6 CYS B 397 THR B 406 -1 N VAL B 404 O VAL B 411
SHEET 3 F 6 THR B 30 CYS B 39 -1 N TYR B 36 O LYS B 400
SHEET 4 F 6 VAL B 130 ASN B 136 -1 O VAL B 134 N SER B 35
SHEET 5 F 6 ILE B 114 ALA B 118 -1 N GLU B 115 O GLU B 135
SHEET 6 F 6 HIS B 459 THR B 460 -1 O HIS B 459 N ALA B 118
SHEET 1 G 2 GLU B 56 PHE B 59 0
SHEET 2 G 2 SER B 123 PRO B 126 -1 O SER B 123 N PHE B 59
SHEET 1 H 5 LEU B 190 ASP B 192 0
SHEET 2 H 5 VAL B 378 SER B 382 1 O PHE B 380 N HIS B 191
SHEET 3 H 5 LEU B 348 GLY B 353 1 N GLN B 352 O SER B 379
SHEET 4 H 5 LEU B 308 ARG B 311 1 N LEU B 308 O ARG B 349
SHEET 5 H 5 VAL B 274 VAL B 277 1 N VAL B 274 O ILE B 309
SHEET 1 I 2 SER B 431 ARG B 434 0
SHEET 2 I 2 PHE B 440 LEU B 443 -1 O LEU B 443 N SER B 431
SITE 1 AC1 16 PHE A 193 ARG A 196 ASP A 219 VAL A 242
SITE 2 AC1 16 ILE A 309 ARG A 311 ASP A 313 ARG A 349
SITE 3 AC1 16 VAL A 350 ILE A 351 GLY A 353 GLU A 376
SITE 4 AC1 16 SER A 379 ASP B 16 TYR B 18 ARG B 392
SITE 1 AC2 19 TYR A 18 TYR B 188 LYS B 189 PHE B 193
SITE 2 AC2 19 ARG B 196 ASP B 219 VAL B 242 ALA B 244
SITE 3 AC2 19 SER B 275 ILE B 309 ARG B 311 ASP B 313
SITE 4 AC2 19 ARG B 349 VAL B 350 GLY B 353 GLU B 376
SITE 5 AC2 19 ASN B 377 VAL B 378 SER B 379
CRYST1 83.316 107.406 120.195 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.012002 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009310 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008320 0.00000